This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sweeney, C. Articles by Slattery, M. L. Search for Related Content PubMed PubMed Citation Articles by Sweeney, C. Articles by Slattery, M. L.

Haplotype Analysis of Common Vitamin D Receptor Variants and Colon and Rectal Cancers

¹ Health Research Center, Department of Family and Preventive Medicine, University of Utah, Salt Lake City, Utah; ² Kaiser Permanente Medical Research Program, Oakland, California; and ³ Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington

Requests for reprints: Carol Sweeney, Health Research Center, Department of Family and Preventive Medicine, University of Utah, 375 Chipeta Way, Suite A, Salt Lake City, UT 84108. Phone: 801-581-5865; Fax: 801-581-3623. E-mail: Carol.Sweeney{at}hrc.utah.edu

Inherited variants of the vitamin D receptor (VDR) gene may influence cancer risk by altering the effect of vitamin D on cell growth and homeostasis. Studies have examined genotypes for common VDR polymorphisms, including a single nucleotide polymorphism (SNP) detected by Bsm1, a polyadenosine [poly(A)] repeat polymorphism, and a SNP detected by Fok1, as candidates for susceptibility to cancer, but most have not evaluated haplotypes for these markers. We investigated haplotypes for these polymorphisms in case-control studies of colon cancer (1,811 cases and 1,451 controls) and rectal cancer (905 cases and 679 controls). We used the expectation-maximization algorithm to estimate haplotypes for White, Hispanic, African-American, and Asian subjects, tested for differences in VDR haplotype distribution, and calculated odds ratios (OR) for association between haplotype and cancer. The distribution of haplotypes differed by race or ethnic group, but four common haplotypes accounted for the majority of alleles in all groups. VDR haplotype distributions differed between colon cancer cases and controls (P = 0.0004). The common haplotype bLF, containing Bsm1 b (Bsm1 restriction site present), poly(A) long (18-22 repeats), and Fok1 F (restriction site absent) was associated with increased risk of colon cancer, OR 1.15 (95% confidence interval, 1.03-1.28), as was the rare haplotype BLF, containing Bsm1 B (restriction site absent), poly(A) long, and Fok1 F (OR, 2.40; 95% confidence interval, 1.43-4.02). No case-control differences were detected for rectal cancer. In this analysis, haplotypes of the VDR influenced risk of colon cancer, but haplotype variables had only slightly better ability to explain case-control differences than genotype variables. (Cancer Epidemiol Biomarkers prev 2006;15(4):744–9)

This article has been cited by other articles:

				M. Sinotte, F. Rousseau, P. Ayotte, E. Dewailly, C. Diorio, Y. Giguere, S. Berube, and J. Brisson Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population Endocr. Relat. Cancer, December 1, 2008; 15(4): 975 - 983. [Abstract] [Full Text] [PDF]

				R. S. Heist, W. Zhou, Z. Wang, G. Liu, D. Neuberg, L. Su, K. Asomaning, B. W. Hollis, T. J. Lynch, J. C. Wain, et al. Circulating 25-Hydroxyvitamin D, VDR Polymorphisms, and Survival in Advanced Non-Small-Cell Lung Cancer J. Clin. Oncol., December 1, 2008; 26(34): 5596 - 5602. [Abstract] [Full Text] [PDF]

				H. M. Ochs-Balcom, M. S. Cicek, C. L. Thompson, T. C. Tucker, R. C. Elston, S. J.Plummer, G. Casey, and L. Li Association of vitamin D receptor gene variants, adiposity and colon cancer Carcinogenesis, September 1, 2008; 29(9): 1788 - 1793. [Abstract] [Full Text] [PDF]

				T. S. Jones, S. C. Kaste, W. Liu, C. Cheng, W. Yang, K. G. Tantisira, C.-H. Pui, and M. V. Relling CRHR1 Polymorphisms Predict Bone Density in Survivors of Acute Lymphoblastic Leukemia J. Clin. Oncol., June 20, 2008; 26(18): 3031 - 3037. [Abstract] [Full Text] [PDF]

				M. L. Slattery, J. Herrick, R. K. Wolff, B. J. Caan, J. D. Potter, and C. Sweeney CDX2 VDR Polymorphism and Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2752 - 2755. [Abstract] [Full Text] [PDF]

				M. L. Slattery, K. Curtin, R. Baumgartner, C. Sweeney, T. Byers, A. R. Giuliano, K. B. Baumgartner, and R. R. Wolff IL6, Aspirin, Nonsteroidal Anti-inflammatory Drugs, and Breast Cancer Risk in Women Living in the Southwestern United States Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 747 - 755. [Abstract] [Full Text] [PDF]